Insider Transactions in Q4 2022 at Galectin Therapeutics Inc (GALT)
Insider Transaction List (Q4 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 30
2022
|
Joel Lewis President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
15,487
+2.17%
|
$15,487
$1.13 P/Share
|
|
Dec 15
2022
|
Joel Lewis President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
15,086
+2.16%
|
$15,086
$1.16 P/Share
|
|
Nov 30
2022
|
Joel Lewis President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
13,780
+2.02%
|
$13,780
$1.27 P/Share
|
|
Nov 17
2022
|
Jack W Callicutt Chief Financial Officer |
BUY
Open market or private purchase
|
Direct |
4,000
+34.44%
|
$4,000
$1.32 P/Share
|
|
Nov 15
2022
|
Joel Lewis President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
14,113
+2.11%
|
$14,113
$1.24 P/Share
|
|
Oct 31
2022
|
Joel Lewis President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
12,681
+1.94%
|
$12,681
$1.38 P/Share
|
|
Oct 28
2022
|
Kevin D Freeman |
BUY
Open market or private purchase
|
Indirect |
10,000
+11.76%
|
$10,000
$1.41 P/Share
|
|
Oct 14
2022
|
Joel Lewis President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
10,802
+1.69%
|
$10,802
$1.62 P/Share
|